Back to Search Start Over

Best practices for the development, scale-up, and post-approval change control of IR and MR dosage forms in the current quality-by-design paradigm.

Authors :
Van Buskirk GA
Asotra S
Balducci C
Basu P
DiDonato G
Dorantes A
Eickhoff WM
Ghosh T
González MA
Henry T
Howard M
Kamm J
Laurenz S
MacKenzie R
Mannion R
Noonan PK
Ocheltree T
Pai U
Poska RP
Putnam ML
Raghavan RR
Ruegger C
Sánchez E
Shah VP
Shao ZJ
Somma R
Tammara V
Thombre AG
Thompson B
Timko RJ
Upadrashta S
Vaithiyalingam S
Source :
AAPS PharmSciTech [AAPS PharmSciTech] 2014 Jun; Vol. 15 (3), pp. 665-93. Date of Electronic Publication: 2014 Mar 01.
Publication Year :
2014

Abstract

In this whitepaper, the Manufacturing Technical Committee of the Product Quality Research Institute provides information on the common, best practices in use today in the development of high-quality chemistry, manufacturing and controls documentation. Important topics reviewed include International Conference on Harmonization, in vitro-in vivo correlation considerations, quality-by-design approaches, process analytical technologies and current scale-up, and process control and validation practices. It is the hope and intent that this whitepaper will engender expanded dialog on this important subject by the pharmaceutical industry and its regulatory bodies.

Details

Language :
English
ISSN :
1530-9932
Volume :
15
Issue :
3
Database :
MEDLINE
Journal :
AAPS PharmSciTech
Publication Type :
Academic Journal
Accession number :
24578237
Full Text :
https://doi.org/10.1208/s12249-014-0087-x